Kowieski Mark has filed 6 insider transactions across 1 company since August 2024.
Most recent transaction: a transaction of 11815 shares of Evoke Pharma Inc ($EVOK) on December 16, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 16, 2025 | Evoke Pharma Inc | $EVOK | Kowieski Mark | Chief Financial Officer | U | Common Stock | 11815 | $0.00 | 0.0000 | 2,557,408 | 100.00% | 0.46% |
| Dec. 17, 2025 | Evoke Pharma Inc | $EVOK | Kowieski Mark | Chief Financial Officer | D | Stock Option (Right to Buy) | 17291 | $0.00 | 0.0000 | 2,557,408 | 100.00% | 0.68% |
| Dec. 17, 2025 | Evoke Pharma Inc | $EVOK | Kowieski Mark | Chief Financial Officer | D | Stock Option (Right to Buy) | 13000 | $0.00 | 0.0000 | 2,557,408 | 100.00% | 0.51% |
| March 20, 2025 | Evoke Pharma Inc | $EVOK | Kowieski Mark | Chief Financial Officer | A | Common Stock | 4500 | $3.21 | 4,916.0000 | 1,905,072 | 1081.73% | 0.24% |
| Jan. 28, 2025 | Evoke Pharma Inc | $EVOK | Kowieski Mark | Chief Financial Officer | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 1,905,072 | 9999.99% | 0.68% |
| Aug. 7, 2024 | Evoke Pharma Inc | $EVOK | Kowieski Mark | Chief Financial Officer | A | Stock Option (Right to Buy) | 17291 | $0.00 | 17,291.0000 | 278,558 | 9999.99% | 6.21% |